7-BENZYL-4-(2-MÉTHYLBENZYL)-2,4,6,7,8,9-HEXAHYDROIMIDAZO[1,2-A]PYRIDO[3,4-E]PYRIMIDIN-5(1H)-ONE, ANALOGUES ET SELS DE CE COMPOSÉ ET LEUR UTILISATION EN THÉRAPIE
Inc.;Oncoceutics, Inc.;Oncoceutics;Provid Pharmaceuticals Inc.
发明人:
STOGNIEW, Martin,ALLEN, Joshua E.,POTTORF, Richard S.,NALLAGANCHU, Bhaskara Rao,OLSON, Gary L.,SUN, Yanjun
申请号：
EP16744237
公开号：
EP3250208A4
申请日:
2016.01.29
申请国别(地区):
EP
年份:
2018
代理人:
摘要：
as defined in the specification, and pharmaceutically acceptable salts thereof, as well as pharmaceutical compositions comprising the same. Methods of treatment, such as for cancer, are provided that comprise administering the compounds and their salts to a subject in need of such treatment.
